Zika virus (
ZIKV)
infection causes devastating
congenital abnormities and Guillain-Barre'
syndrome. The
ZIKV envelope (E)
protein is responsible for
viral entry and represents a major determinant for viral
pathogenesis. Like other
flaviviruses, the
ZIKV E
protein is glycosylated at
amino acid N154. To study the function of E
glycosylation, we generated a recombinant N154Q
ZIKV that lacks the E
glycosylation and analyzed the mutant
virus in mammalian and
mosquito hosts. In
mouse models, the mutant was attenuated, as evidenced by lower
viremia, decreased
weight loss, and no
mortality; however, knockout of E
glycosylation did not significantly
affect neurovirulence.
Mice immunized with the mutant
virus developed a robust
neutralizing antibody response and were completely protected from wild-type
ZIKV challenge. In
mosquitoes, the mutant
virus exhibited diminished oral infectivity for the
Aedes aegypti vector. Collectively, the results demonstrate that E
glycosylation is critical for
ZIKV infection of mammalian and
mosquito hosts